Minimal hepatic encephalopathy is associated to alterations in eye movements

Autores de CIPF
Participantes ajenos a CIPF
- Casanova-Ferrer, F
- Garcia-Cena, CE
- Gallego, JJ
- Fiorillo, A
- Calvo-Cordoba, A
- Ballester, MP
- Rios, MP
- Durban, L
Grupos de Investigación
Abstract
Minimal hepatic encephalopathy (MHE) is diagnosed using PHES battery, but other tests are more sensitive, and a simple tool for early MHE detection is required. Assessment of saccadic eye movements is useful for early detection of cognitive alterations in different pathologies. We characterized the alterations in saccadic eye movements in MHE patients, its relationship with cognitive alterations and its utility for MHE diagnosis. One-hundred and eighteen cirrhotic patients (86 without and 32 with MHE) and 35 controls performed PHES and Stroop test and an eye movements test battery by OSCANN system: visual saccades, antisaccades, memory-guided saccades, fixation test and smooth pursuit. We analyzed 177 parameters of eye movements, assessed their diagnostic capacity for MHE, and correlated with cognitive alterations. MHE patients showed alterations in 56 of the 177 variables of eye movements compared to NMHE patients. MHE patients showed longer latencies and worse performance in most eye movements tests, which correlated with mental processing speed and attention impairments. The best correlations found were for antisaccades and memory-guided saccades, and some parameters in these tests could be useful for discriminating MHE and NMHE patients. Eye movements analysis could be a new, rapid, reliable, objective, and reproducible tool for early diagnose MHE.
Datos de la publicación
- ISSN/ISSNe:
- 2045-2322, 2045-2322
- Tipo:
- Article
- Páginas:
- 16837-16837
- PubMed:
- 36207472
Scientific Reports NATURE PUBLISHING GROUP
Citas Recibidas en Web of Science: 4
Documentos
- No hay documentos
Filiaciones
Financiación
Proyectos asociados
PID10470. No se ingresará dinero en el CIPF. La ayuda consiste en un estudio genómico (long & read-sequencing) para 25 muestras.
Investigador Principal: CARMEN ESPINÓS ARMERO
EASI- Genomics . 2020
Mecanismos moleculares de las alteraciones neurológicas (cognitivas y motoras) en hiperamonemia y encefalopatía hepática. Implicaciones terapéuticas.
Investigador Principal: VICENTE FELIPO ORTS
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2021
Molecular mechanisms of the neurological (cognitive and motor) alterations in hyperammonemia and hepatic encephalopathy. Therapeutic implications.
Investigador Principal: VICENTE FELIPO ORTS
CONSELLERIA DE EDUCACION . 2022
Nanoplataforma Polipeptídica Multimodal de Precisión para el Tratamiento y Monitorización de Tumores Metastásicos. Colab I-36, I-12, I-63, servicio citómica, uji y gva (Esther Roselló)
Investigador Principal: MARIA JESUS VICENT DOCON
CONSELLERIA DE EDUCACION . 2022
ESTUDIO DE LAS DIFERENCIAS DE SEXO EN ENFERMEDADES NEURODEGENERATIVAS CON ABORDAJES
Investigador Principal: FRANCISCO GARCÍA GARCÍA
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2022